학술논문
Successful Treatment of Full-Thickness Macular Hole in Polypoidal Choroidal Vasculopathy With Anti-VEGF Therapy
Document Type
Article
Source
Journal of VitreoRetinal Diseases; October 2020, Vol. 4 Issue: 5 p433-436, 4p
Subject
Language
ISSN
24741264; 24741272
Abstract
Purpose: This report discusses the case of an 86-year-old man with a full-thickness macular hole (FTMH) secondary to polypoidal choroidal vasculopathy (PCV) treated with bevacizumab.Methods: A case report is presented.Results: An 86-year-old man presented with a 5-month history of metamorphopsia and decreased vision in his right eye and was found to have active exudation secondary to PCV with a concurrent FTMH. After 4 treatments with intravitreal bevacizumab, the FTMH resolved without surgical intervention.Conclusions: The patient’s FTMH resolved with solely pharmacologic treatment as a result of treating his PCV with intravitreal bevacizumab. Macular hole formation secondary to PCV is a rare finding, but may be successfully treated with pharmacologic therapy without surgical intervention.